Anthropic is making it easier for patients and clinicians to use its artificial intelligence chatbot to access medical information, part of a broader push into the lucrative health care sector. The San Francisco-based company on Sunday said that its Claude pr…

The stocks of Broadcom and AMD could have higher upside than Nvidia in the coming years.

The pared-down space at Hudson's Detroit puts executives near local decision-makers while embracing CEO Mary Barra's strategy to go where talent is.

The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).

Another wave of closures has hit Macy’s, with over a dozen locations set to shutter across the nation in the coming months, including one near the Bay Area.

“It was extremely difficult,” IgniteTech CEO Eric Vaughan tells Fortune. “But changing minds was harder than adding skills.”

Nvidia (NVDA) CEO Jensen Huang has just cut through the big debate over AI chipmaking, saying that the future of advanced chips runs through Taiwan. By...

A wave of first-generation vehicles is making way for their next-gen replacements — and, historically, that's when buyers get the best deals.

‘We are seeing oil, gold and silver rally as geopolitical tensions are rising, especially after the military operation in Venezuela,’ says one CIO

GameStop is shutting down over 400 stores as the CEO races for $35 billion payday.

America’s AI boom is driving a surge in data center construction—along with rising water demand. Why water is becoming the hidden constraint on AI infrastructure.

Plus, tech billionaires’ ‘Save California’ Signal chat, highlights from the year’s biggest gadget show, the woman running SpaceX and more, in this edition of the Technology newsletter

The super-sized gathering of the biopharma universe known as JPM is important, but it’s not going to make or break the year for biotech, Adam Feuerstein writes.

Such experiments have previously only been conducted aboard the International Space Station.

The reclassification is tied to the detection of Listeria monocytogenes, a bacteria that can cause severe illness.

Private biotechs raised $1B+ pre-JPM conference, led by Parabilis' $305M Series F. Public companies like Arrowhead ($625M) & Alumis ($300M) also secured funding amid sector optimism.

Market Questions is the FT’s guide to the week ahead

Two-thirds of financial advisors are changing their retirement investment advice for clients due to a volatile market and economic uncertainty.

The 2026 Social Security COLA is finalized and retirees will start getting their checks this month -- but unfortunately, they're taking a major financial hit.

A gathering of pharmaceutical executives comes as the sector has rebounded from uncertainty over Trump’s policies

President demands curbs to shareholder returns and pay but also holds out prospect of military spending bonanza

Academics including France’s Thomas Piketty press MEPs to resist ‘shortsighted’ lobbying against the project

Hailey Bieber always makes us swoon with her incomparably chic outfit choices. She loves to make onlookers’ hearts flutter with some of the most trend-worthy...

Golden Globes 2026: Every Celebrity Couple on the Red Carpet